↓ Skip to main content

New Trends in Cancer for the 21st Century

Overview of attention for book
Cover of 'New Trends in Cancer for the 21st Century'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Driving the Cell Cycle to Cancer
  3. Altmetric Badge
    Chapter 2 Proliferation: The Cell Cycle
  4. Altmetric Badge
    Chapter 3 Molecular Analysis of Gene Expression in Tumor Pathology
  5. Altmetric Badge
    Chapter 4 Ewing Tumor Biology: Perspectives for Innovative Treatment Approaches
  6. Altmetric Badge
    Chapter 5 Cancer Epigenetics: DNA Methylation and Chromatin Alterations in Human Cancer
  7. Altmetric Badge
    Chapter 6 Molecular analysis of cancer using DNA and protein microarrays.
  8. Altmetric Badge
    Chapter 7 Proteomic Approaches to the Diagnosis, Treatment, and Monitoring of Cancer
  9. Altmetric Badge
    Chapter 8 Structural Basis of Tumoral Angiogenesis
  10. Altmetric Badge
    Chapter 9 Matrix Metalloproteinases and Tumor Progression
  11. Altmetric Badge
    Chapter 10 Angiogenesis inhibitors and their therapeutic potentials.
  12. Altmetric Badge
    Chapter 11 Mutated Tyrosine Kinases As Therapeutic Targets In Myeloid Leukemias
  13. Altmetric Badge
    Chapter 12 Targeting PDGF receptors in cancer--rationales and proof of concept clinical trials.
  14. Altmetric Badge
    Chapter 13 Immune-Promoted Tumor Cell Invasion and Metastasis
  15. Altmetric Badge
    Chapter 14 Improvements of Survival in Nine Phase II Clinical Studies with Different Types of Cancer Upon Anti- Tumor Vaccination with an Autologous Tumor Cell Vaccine Modified by Virus Infection to Introduce Danger Signals
  16. Altmetric Badge
    Chapter 15 Causation and Prevention of Solely Estrogen- Induced Oncogenesis: Similarities to Human Ductal Breast Cancer
  17. Altmetric Badge
    Chapter 16 Cyclooxygenase-2 Inhibitors in Cancer Prevention and Treatment
  18. Altmetric Badge
    Chapter 17 Exosomes for immunotherapy of cancer.
  19. Altmetric Badge
    Chapter 18 Breast Cancer Gene Expression Analysis
  20. Altmetric Badge
    Chapter 19 Development of The Epidermal Growth Factor Receptor Inhibitor Tarceva™(OSI-774)
  21. Altmetric Badge
    Chapter 20 Gefitinib (Iressa, ZD 1839) for non-small cell lung cancer (NSCLC): recents results and further strategies.
  22. Altmetric Badge
    Chapter 21 Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4.
  23. Altmetric Badge
    Chapter 22 EORTC Research and Development: Achievements and Future Perspectives
Attention for Chapter 17: Exosomes for immunotherapy of cancer.
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Exosomes for immunotherapy of cancer.
Chapter number 17
Book title
New Trends in Cancer for the 21 st Century
Published in
Advances in experimental medicine and biology, January 2003
DOI 10.1007/978-1-4615-0081-0_17
Pubmed ID
Book ISBNs
978-1-4613-4914-3, 978-1-4615-0081-0
Authors

Chaput, Nathalie, Schartz, N E C, Andre, Fabrice, Zitvogel, Laurence, Schartz, N. E. C.

Abstract

Exosomes are 60 to 90 nm membrane vesicles originating from late endosomes and secreted from most hematopoietic and epithelial cells in vitro. B cell derived-exosome antigenicity was first reported in 1996 in MHC class II restricted CD4+ T lymphocytes. In 1998, we reported that dendritic cell derived-exosomes are immunogenic in mice leading to tumor rejection. These findings have renewed the interest in exosomes. The current challenge consists in understanding the mechanisms and the physiological relevance of exosomes that could contribute to the design of the optimal exosome based-vaccination. Here, we will focus on the biological features pertaining to dendritic cell- and tumor cell derived-exosomes and will discuss their potential clinical implementation.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 18%
Student > Ph. D. Student 5 15%
Student > Master 4 12%
Professor > Associate Professor 3 9%
Professor 3 9%
Other 4 12%
Unknown 9 26%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 26%
Medicine and Dentistry 6 18%
Immunology and Microbiology 4 12%
Biochemistry, Genetics and Molecular Biology 2 6%
Neuroscience 2 6%
Other 2 6%
Unknown 9 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2012.
All research outputs
#20,176,348
of 22,689,790 outputs
Outputs from Advances in experimental medicine and biology
#3,929
of 4,902 outputs
Outputs of similar age
#126,427
of 128,933 outputs
Outputs of similar age from Advances in experimental medicine and biology
#15
of 18 outputs
Altmetric has tracked 22,689,790 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,902 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 128,933 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.